AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 221 filers reported holding AMICUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $442 | +0.9% | 36,377 | +4.3% | 0.03% | -2.9% |
Q2 2023 | $438 | +17.1% | 34,867 | +3.3% | 0.04% | +29.6% |
Q1 2023 | $374 | -15.4% | 33,758 | -6.6% | 0.03% | -27.0% |
Q4 2022 | $442 | -99.9% | 36,161 | -13.3% | 0.04% | -7.5% |
Q3 2022 | $435,000 | -22.7% | 41,712 | -20.5% | 0.04% | -21.6% |
Q2 2022 | $563,000 | +106.2% | 52,439 | +81.6% | 0.05% | +466.7% |
Q1 2022 | $273,000 | +40.0% | 28,875 | +71.2% | 0.01% | +28.6% |
Q4 2021 | $195,000 | +29.1% | 16,869 | +7.0% | 0.01% | +16.7% |
Q3 2021 | $151,000 | +18.9% | 15,771 | +22.6% | 0.01% | -40.0% |
Q1 2021 | $127,000 | – | 12,862 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |